{"id":24021,"date":"2021-02-16T04:14:03","date_gmt":"2021-02-16T09:14:03","guid":{"rendered":"http:\/\/b0xninjaz.net\/kk4kmo\/?p=24021"},"modified":"2021-02-16T04:17:46","modified_gmt":"2021-02-16T09:17:46","slug":"full-service-cdmo-for-a-worldwide-market-3","status":"publish","type":"post","link":"http:\/\/b0xninjaz.net\/kk4kmo\/?p=24021","title":{"rendered":"FULL-SERVICE CDMO FOR A WORLDWIDE MARKET"},"content":{"rendered":"<p><title>FULL-SERVICE CDMO FOR A WORLDWIDE MARKET<\/title><\/p>\n<h2>Tech Platforms<\/h2>\n<h2>Peptides, Lipids &amp; Carbs<\/h2>\n<h2>Definitely Potent &amp; Oncology<\/h2>\n<h2>Injectables<\/h2>\n<h2>Small Particles<\/h2>\n<h2>Antibiotics<\/h2>\n<h2>Full-Service, Fully Committed<\/h2>\n<p>CordenPharma, the worldwide service that is pharmaceutical production platform of Global Chemical Investors Group (ICIG), is just a full-service Contract developing &amp; production Organization (CDMO) for the manufacturing of APIs, Drug goods, and linked Packaging Services. Via a network that is growing of opportunities across Europe as well as the United States arranged under Technology Platforms, CordenPharma experts translate complex processes, tips and jobs at any phase of development into high-value services and products.<\/p>\n<h2>Active Pharmaceutical Ingredients<\/h2>\n<h2>OralDrug items<\/h2>\n<h2>InjectableDrug Products<\/h2>\n<h2>Pharma Packaging&amp; Logistics<\/h2>\n<h2>Integrated Provide<\/h2>\n<p>CordenPharma??\u2122s supply that is vertically-integrated model provides development &amp; production expertise spanning the whole cGMP supply chain &gt; from regulated recycleables through intermediates, APIs, commercial-scale Drug Product manufacturing, completed dosage formula, packaging, medical test services, &amp; pharma logistics &gt; resulting in paid off development &amp; manufacturing some time expense.<\/p>\n<h2>News &amp; Press<\/h2>\n<h2>CDMO Expands US Peptide Production Capability<\/h2>\n<h2>Molecule to promote Podcast: A CDMO from the frontline<\/h2>\n<h2>LIVE WEBINAR &gt; Your Roadmap that is injectable for Drug Product-Device Regulations &amp; Capabilities in the New Normal<\/h2>\n<p>TUES OCT 13 at 16:00 CEST \/ 10:00 EDT &gt; JOIN HERE<\/p>\n<h2>Donate to our Publication<\/h2>\n<p>Remain as much as date with all the thought leadership articles that are latest and news from CordenPharma.<\/p>\n<h2>TIDES VIRTUAL 2020 &gt; Sept 15-18<\/h2>\n<h2>Upcoming Occasions<\/h2>\n<h2>BioMed<\/h2>\n<h2>EVENT CANCELLED<\/h2>\n<h2>Sept 7 &#8211; 9, 2020<\/h2>\n<p>David Intercontinental Tel Aviv, Israel Event website<\/p>\n<h2>CPhI united states<\/h2>\n<h2>EVENT CANCELLED<\/h2>\n<h2>Sept 9 &#8211; 11, 2020<\/h2>\n<p>Pennsylvania Convention Center Philadelphia, PA United States Of America Event internet site<\/p>\n<p><!--more--><\/p>\n<h2>ChemOutsourcing<\/h2>\n<h2>never ATTENDING<\/h2>\n<h2>September 14 &#8211; 15, 2020<\/h2>\n<p>Ocean Spot Resort Long Branch, NJ USA Event site<\/p>\n<h2>Site Library<\/h2>\n<p>Browse our collection of Brochures, Product Lists, White Papers, Videos &amp; Webinars.<\/p>\n<h2>E MAIL US<\/h2>\n<p>Put an inquiry right here &gt; one of y our group of professionals gets back again to you.<\/p>\n<p>?\u00a92020 CordenPharma Global<\/p>\n<h2>Dr. Lee Newton Chief Operating Officer, CordenPharma<\/h2>\n<p>Dr. Lee Newton joins CordenPharma from Lonza, where he of late held the part of Senior Vice President &amp; Business device mind for Lonza??\u2122s Small Molecule API business. Lee has over two decades of expertise inside the Pharmaceutical business. After starting his job in main production with GlaxoWellcome, Lee relocated to the CDMO sector in 2002 with Avecia, and it has since worked in a variety of operational &amp; commercial functions with increasing obligation including as Operations Director for Carbogen Amcis. A PhD is held by him in Organic Chemistry through the University of Heriot-Watt (UK). Lee is Scottish nationwide currently surviving in Switzerland.<\/p>\n<h2>William Cashin Chief Quality &amp; Compliance Officer, CordenPharma<\/h2>\n<p>William Cashin joined up with CordenPharma as Chief Quality &amp; Compliance Officer in might 2020. Will joins us from Lonza, where he served as international Head Quality, Mammalian and Microbial. In this part, he had been straight in charge of every aspect of quality for biopharmaceutical manufacturing that is global within Europe, the united states, Singapore and Asia. Ahead of that, Will worked extensively into the industry that is pharmaceutical including functions of increasing duty at Alexion, GSK and Pfizer. He holds a Bachelor??\u2122s level in Applied Chemistry through the Waterford Institute of tech in Ireland and a Master??\u2122s level in operation management from the Open University, (UK). William can be an Irish nationwide, currently situated in Switzerland.<\/p>\n<p>Just click here to tell us of any urgent concerns or issues. CEO Movie Modify <\/p>\n<h2>Dr. Walter Kittl Interim Managing Director, CordenPharma Plankstadt<\/h2>\n<p>Dr. Walter Kittl could be the Interim Managing Director, CordenPharma Plankstadt, beginning March 19, 2020. With more than 35 several years of expertise in the pharmaceutical, CMO and fine chemical industries, Walter brings a holistic comprehension of pharmaceutical production operations caused by a multi-faceted job starting as a venture Manager in R&amp;D and manufacturing at DSM Fine Chemicals. Walter then held various management that is senior with increasing quantities of duty at Roche, where he became Site Manager associated with the Basel Chemical production web site, and Siegfried AG, where he had been President &amp; <a href=\"https:\/\/datingstreet.net\/swinglifestyle-review\/\">swinglifestyle.com sign in<\/a> General Manager of Siegfried USA before becoming the pinnacle of Global Technical Operations. Walter is definitely A austrian citizen and holds a Ph.D. in Chemistry through the Leopold-Franzens University of Innsbruck, Austria.<\/p>\n<h2>Benis Cehic Managing Director, CordenPharma Plankstadt<\/h2>\n<p>Benis Cehic joined up with CordenPharma as Managing Director, CordenPharma Plankstadt in January 2020. Ahead of joining CordenPharma, Benis held different senior roles into the pharmaceutical industry with over a decade of expertise. Benis Cehic began their job during the company that is pharmaceutical, d.d., Slovenia, where he had been in charge of commercial creation of APIs including particular transfers to CMOs and scale-ups of technologies. Since 2013, Benis held different senior roles at BAYER HealthCare and Animal Health into the regions of international exterior Manufacturing, and much more recently within BAYER??s worldwide provide Center of finished items in Kiel, Germany, where he held executive that is distinct leadership roles with increasing duty, including overseeing technology transfers and life-cycle administration. He had been accountable and in charge of the method device solids in packaging and formulation of pills, along with leading your website engineering group. Moreover, Benis had been a deputy handling Director during the provide Center Kiel. He holds a Chemical Engineering level from University of Ljubljana, Slovenia and then he complemented their studies with extra courses such as for example Lean Professional and Executive company &amp; Management studies during the ESADE company class in Barcelona, Spain.<\/p>\n<h2>Jason Bertola Director, Worldwide Definitely Potent &amp; Oncology System, CordenPharma Overseas<\/h2>\n<p>Jason Bertola joined up with CordenPharma in 2016 as Director, worldwide Highly Potent &amp; Oncology system, CordenPharma Global. Jason started their profession in pharmaceutical process development first with SAPEC (now Cerbios) after which Hoffmann-La Roche before transitioning into business development and product sales. He brings over 27 years of diverse leadership experience with the pharmaceutical industry with substantial expertise in agreement development and production, strategy development and company deals. Just before CordenPharma that is joining ended up being Vice President of company developing &amp; Strategy for Dishman. Jason holds a B.S. in Chemistry plus an MBA from Fairleigh Dickinson University.<\/p>\n<h2>Dr. Stephen Houldsworth VP, Global Mind of Platform Management &amp; Marketing, CordenPharma Global<\/h2>\n<p>Dr. Stephen Houldsworth happens to be the VP, international mind of system Management &amp; advertising. With more than two decades into the CDMO industry, Stephen joined CordenPharma in 2017 as Director, international Small Molecules &amp; Antibiotics Platforms. Ahead of CordenPharma that is joining Stephen different senior roles in R&amp;D, production, Operations, company developing and product Sales in Dalton Pharma Services &amp; most recently Apotex Pharmachem. Stephen has a Ph.D. in natural chemistry through the University of Nottingham (UK) where he carried out research when you look at the number of Prof. G. Pattenden, accompanied by a postdoctoral stay static in the selection of V. Snieckus during the University of Waterloo (CA).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>FULL-SERVICE CDMO FOR A WORLDWIDE MARKET Tech Platforms Peptides, Lipids &amp; Carbs Definitely Potent &amp; Oncology Injectables Small Particles Antibiotics Full-Service, Fully Committed CordenPharma, the worldwide service that is pharmaceutical production platform of Global Chemical Investors Group (ICIG), is just a full-service Contract developing &amp; production Organization (CDMO) for the manufacturing of APIs, Drug goods, <a class=\"read-more\" href=\"http:\/\/b0xninjaz.net\/kk4kmo\/?p=24021\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=\/wp\/v2\/posts\/24021"}],"collection":[{"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24021"}],"version-history":[{"count":1,"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=\/wp\/v2\/posts\/24021\/revisions"}],"predecessor-version":[{"id":24022,"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=\/wp\/v2\/posts\/24021\/revisions\/24022"}],"wp:attachment":[{"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24021"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/b0xninjaz.net\/kk4kmo\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}